|
|
Jazz Pharmaceuticals Plc (JAZZ) |
|
|
|
Jazz Pharmaceuticals Plc's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
JAZZ Annual EPS from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual EPS from Cont. Operations Change |
- |
- |
- |
-53.58 % |
23.76 % |
Annual EPS from Cont. Operations (in $) |
$6.55 |
$-3.58 |
$-5.52 |
$4.28 |
$9.22 |
Annual EPS from Cont. Operations Growth
Comment |
In the fiscal year ended 2023, company achieved Annual EPS from Cont. Operations of $6.55 compare to EPS loss from Cont. Operations of $-3.58 realized a year before.
Jazz Pharmaceuticals Plc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2023 Annual EPS from Cont. Operations | Cassava Sciences Inc | | | |